SCHEMBL8426348

SCHEMBL8426348

NC(C(=O)O)C(O)COCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 4/20 0.59
SLC1A3 P43003 3/20 0.57
SLC1A2 P43004 3/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
CA1 P00915 3/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
TACR1 P25103 4/20 0.50
FOLH1 Q04609 1/20 0.46
MAPK1 P28482 1/20 0.46
TSHR P16473 1/20 0.45
ALPI P09923 1/20 0.44
PKM P14618 1/20 0.44
PTGS1 P23219 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27931897 1.00 SLC1A1 (0.59) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL8836944 1.00 SLC1A1 (0.59) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL5286295 0.84 SLC1A1 (0.54) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL21853773 0.84 SLC1A1 (0.54) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL724210 0.82 SLC1A1 (0.57) SLC1A1SLC1A3SLC1A2KMT2AMEN1
SCHEMBL4382418 0.82 CA1 (0.66) SLC1A1KMT2ACA1CA2CA7
SCHEMBL93708 0.82 CA1 (0.66) SLC1A1KMT2ACA1CA2CA7
SCHEMBL93709 0.82 CA1 (0.66) SLC1A1KMT2ACA1CA2CA7
SCHEMBL4385964 0.82 CA1 (0.66) SLC1A1KMT2ACA1CA2CA7
SCHEMBL8836900 0.81 SLC1A1 (0.51) SLC1A1SLC1A3SLC1A2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962660-A COMPOUND WHICH SUPPRESSES SELECTIN-MEDIATED CELLULAR ADHESION; FOR STABLE ANTIINFLAMMATORY AGENTS WITH BETTER BIOAVAILABILITY AND GREATER ACTIVITY WHICH ARE EASIER TO SYNTHESIZE THE SCRIPPS RESEARCH INSTITUTE (US) 1999-10-05 US disclosed